Wanrudee Isaranuwatchai

PhD

Affiliate Scientist

Biography

Dr. Wanrudee Isaranuwatchai is an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada. She is also a Program Leader and Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), Thailand.

Her research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process.

She has also collaborated with researchers, health professionals, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia, Africa, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making.

Recent Publications

  1. Rattanavipapong, W, Wang, Y, Butchon, R, Kittiratchakool, N, Thammatacharee, J, Teerawattananon, Y et al.. Retrospective secondary data analysis to identify high-cost users in inpatient department of hospitals in Thailand, a middle-income country with universal healthcare coverage. BMJ Open. 2021;11 (7):e047330. doi: 10.1136/bmjopen-2020-047330. PubMed PMID:34321299 .
  2. Painter, C, Isaranuwatchai, W, Prawjaeng, J, Wee, HL, Chua, BWB, Huynh, VA et al.. Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines. Appl Health Econ Health Policy. 2021;19 (4):463-472. doi: 10.1007/s40258-021-00661-5. PubMed PMID:34235643 PubMed Central PMC8263163.
  3. Millar, R, Morton, A, Bufali, MV, Engels, S, Dabak, SV, Isaranuwatchai, W et al.. Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact. Cost Eff Resour Alloc. 2021;19 (1):37. doi: 10.1186/s12962-021-00290-8. PubMed PMID:34215282 PubMed Central PMC8252304.
  4. Pataky, RE, Beca, J, Tran, D, Dai, WF, Dvorani, E, Isaranuwatchai, W et al.. Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces. MDM Policy Pract. ;6 (1):23814683211021060. doi: 10.1177/23814683211021060. PubMed PMID:34212111 PubMed Central PMC8216386.
  5. Sharma, D, Aggarwal, AK, Wilkinson, T, Isaranuwatchai, W, Chauhan, AS, Prinja, S et al.. Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review. Int J Technol Assess Health Care. 2021;37 (1):e73. doi: 10.1017/S0266462321000404. PubMed PMID:34193325 .
  6. Stolee, P, Elliott, J, Giguere, AM, Mallinson, S, Rockwood, K, Sims Gould, J et al.. Transforming primary care for older Canadians living with frailty: mixed methods study protocol for a complex primary care intervention. BMJ Open. 2021;11 (5):e042911. doi: 10.1136/bmjopen-2020-042911. PubMed PMID:33986044 PubMed Central PMC8126280.
  7. Saunders, H, Sujic, R, Bogoch, ER, Jain, R, Jinah, A, Elliot-Gibson, V et al.. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program. J Bone Joint Surg Am. 2021;103 (13):1175-1183. doi: 10.2106/JBJS.20.00795. PubMed PMID:33764937 .
  8. Shickh, S, Rafferty, SA, Clausen, M, Kodida, R, Mighton, C, Panchal, S et al.. The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care. Genet Med. 2021;23 (6):1086-1094. doi: 10.1038/s41436-021-01112-1. PubMed PMID:33654192 .
  9. Kastner, M, Makarski, J, Hayden, L, Hamid, JS, Holroyd-Leduc, J, Twohig, M et al.. Effectiveness of an eHealth self-management tool for older adults with multimorbidity (KeepWell): protocol for a hybrid effectiveness-implementation randomised controlled trial. BMJ Open. 2021;11 (2):e048350. doi: 10.1136/bmjopen-2020-048350. PubMed PMID:33597147 PubMed Central PMC7893667.
  10. Tangcharoensathien, V, Sirilak, S, Sritara, P, Patcharanarumol, W, Lekagul, A, Isaranuwatchai, W et al.. Co-production of evidence for policies in Thailand: from concept to action. BMJ. 2021;372 :m4669. doi: 10.1136/bmj.m4669. PubMed PMID:33593790 PubMed Central PMC7879270.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
X